Authors: Spina, E Avenoso, A Facciola, G Salemi, M Scordo, MG Ancione, M Madia, AG Perucca, E

Citation: E. Spina et al., Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia, PSYCHOPHAR, 153(2), 2001, pp. 238-243

Authors: Spina, E Avenoso, A Scordo, MG Ancione, M Madia, A Levita, A

Citation: E. Spina et al., No effect of reboxetine on plasma concentrations of clozapine, risperidone, and their active metabolites, THER DRUG M, 23(6), 2001, pp. 675-678

Authors: Spina, E Avenoso, A Facciola, G Scordo, MG Ancione, M Madia, A

Citation: E. Spina et al., Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetine, THER DRUG M, 23(3), 2001, pp. 223-227

Authors: Spina, E Avenoso, A Facciola, G Scordo, MG Ancione, M Madia, AG Ventimiglia, A Perucca, E

Citation: E. Spina et al., Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics, PSYCHOPHAR, 148(1), 2000, pp. 83-89

Authors: Spina, E Avenoso, A Salemi, M Facciola, G Scordo, MG Ancione, M Madia, A

Citation: E. Spina et al., Plasma concentrations of clozapine and its major metabolites during combined treatment with paroxetine or sertraline, PHARMACOPS, 33(6), 2000, pp. 213-217